-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VhB23dlZTTpeEnvMNb8VnaFnR6TlBup+2SMX0R1nYXzq8euIrwc/mpEwoRsPKaY9 FWSd0MXqGJPlc6RmJPoVqw== 0001041885-03-000028.txt : 20030304 0001041885-03-000028.hdr.sgml : 20030304 20030304110654 ACCESSION NUMBER: 0001041885-03-000028 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030304 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON LIFE SCIENCES INC /DE CENTRAL INDEX KEY: 0000094784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870277826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-07547 FILM NUMBER: 03590581 BUSINESS ADDRESS: STREET 1: 137 NEWBURY STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174250200 MAIL ADDRESS: STREET 1: 137 NEWBURY STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC MEDICAL RESEARCH CORP /DE DATE OF NAME CHANGE: 19790521 FORMER COMPANY: FORMER CONFORMED NAME: GREENWICH PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: INGALLS & SNYDER LLC CENTRAL INDEX KEY: 0001041885 IRS NUMBER: 135156620 STATE OF INCORPORATION: NY FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 61 BROADWAY STREET 2: C/O INGALLS & SNYDER CITY: NEW YORK STATE: NY ZIP: 100006 BUSINESS PHONE: 2122697812 MAIL ADDRESS: STREET 1: 61 BROADWAY CITY: NEW YORK STATE: NY ZIP: 100006 SC 13G/A 1 blsifix1.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ OMB APPROVAL OMB NUMBER: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response....11 _____________________________ SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3________________)* BOSTON LIFE SCIENCES, INC. ----------------------------------------------------- (Name of Issuer) COMMON STOCK ----------------------------------------------------- (Title of Class of Securities) 100843408 ----------------------------------------------------- (CUSIP Number) 12/31/02 ----------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [X] Rule 13d-1(c) [] Rule 13d-1(d) - ---------- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 100843408 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) INGALLS & SNYDER LLC 13-5156620 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION NEW YORK STATE - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 2,500,000 (see item 6) REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 2,560,000 (See Item 6) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,560,000 (See Item 6) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.87 % (see Item 6) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* BD - -------------------------------------------------------------------------------- CUSIP No. 100843408 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) INGALLS & SNYDER VALUE PARTNERS L.P. 13-3694561 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION NEW YORK STATE - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 2,500,000 (see item 6) REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 2,500,000 (See Item 6) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,500,000 (See Item 6) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.64 % (see Item 6) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- CUSIP No. 100843408 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) THOMAS O BOUCHER JR. - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES OF AMERICA - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 2,500,000 (see item 6) REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 2,500,000 (See Item 6) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,500,000 (See Item 6) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.64 % (see Item 6) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- CUSIP No. 100843408 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) ROBERT L. GIPSON - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES OF AMERICA - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 1,734,000 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 2,500,000 (see item 6) REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 1,734,000 - -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 2,560,000 (See Item 6) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,294,000 (See Item 6) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 16.56 % (see Item 6) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- Item 1. (a) Name of Issuer: BOSTON LIFE SCIENCES INC. -------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices: 20 NEWBURY ST BOSTON, MA 02116 -------------------------------------------------------------- Item 2. (a) Name of Person Filing: A) INGALLS & SNYDER LLC B) INGALLS & SNYDER VALUE PARTNERS, L.P. C) THOMAS O BOUCHER JR. D) ROBERT L. GIPSON -------------------------------------------------------------- (b) Address of Principal Business Office, or if None, Residence: A) 61 BROADWAY, NEW YORK, NY 10006 B) C/O INGALLS & SNYDER LLC 61 BROADWAY, NEW YORK, NY 10006 C) C/O INGALLS & SNYDER LLC 61 BROADWAY, NEW YORK, NY 10006 D) C/O INGALLS & SNYDER LLC 61 BROADWAY, NEW YORK, NY 10006 -------------------------------------------------------------- (c) Citizenship: INCORPORATED BY REFERENCE TO ITEM 4 OF THE COVER PAGE PERTAINING TO EACH REPORTING ENTITY. -------------------------------------------------------------- (d) Title of Class of Securities: COMMON STOCK -------------------------------------------------------------- (e) CUSIP Number: 100843408 -------------------------------------------------------------- Item 3. INGALLS & SNYDER LLC is a Broker/Dealer registered under Section 15 of the Act, (15 U.S.C 78o) and an Investment Adviser in accordance with Section 240.13d-1(b)(1)(ii)(E) Item 4. Ownership. Incorporated by reference to Items (5)-(9) and (11) of the cover pages. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. INAPPLICABLE Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Securities reported by Ingalls & Snyder LLC ("I&S") include securities owned by Ingalls & Snyder Value Partners, L.P. ("ISVP"), an investment partnership managed by I&S under an Investment Advisory contract. Robert L. Gipson, "Gipson", a Senior Director of I&S and Thomas O. Boucher, Jr., a Managing Director of I&S, are the General Partners of ISVP and as such, share the power to vote the shares owned by ISVP. ISVP owns a $4,000,000 convertible senior secured promissory note issued by Boston Life Sciences, Inc., ("BLSI") which may be converted into 2,000,000 shares of BLSI common stock. ISVP also owns 500,000 BLSI warrants. Each warrant gives ISVP the right to purchase one share of BLSI common stock at $2.16. Securities reported under shared dispositive power by I&S include shares held in brokerage accounts over which Gipson holds discretionary investment authority. Shares reported by Gipson include common shares, 50,000 BLSI warrants which give him the right to purchase one share per warrant at a price of $2.15 until 3/1/07, and 1,000,000 warrants which give him the right to purchase one share per warrant at a price of $2.00 until 12/31/06. Securities reported under shared dispositive power include ISVP shares and shares held in other I&S Accounts where Gipson holds discretionary investment authority. All shares reported assume the conversion of the promissory notes and the exercise of all warrants owned by Gipson and ISVP. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. INAPPLICABLE Item 8. Identification and Classification of Members of the Group. INAPPLICABLE Item 9. Notice of Dissolution of Group. INAPPLICABLE Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 3/3/03 INGALLS & SNYDER LLC BY: /s/ EDWARD H. OBERST - ---------------------------------- (Signature)* EDWARD H. OBERST MANAGING DIRECTOR - ---------------------------------- (Name/Title) Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 3/3/03 INGALLS & SNYDER VALUE PARTNERS, L.P. BY: /s/ THOMAS O BOUCHER JR. - ---------------------------------- (Signature)* THOMAS O BOUCHER JR. GENERAL PARTNER - ---------------------------------- (Name/Title) Date: 3/3/03 /s/ THOMAS O BOUCHER JR. - ---------------------------------- (Signature)* THOMAS O. BOUCHER JR. Date: 3/3/03 /s/ ROBERT L. GIPSON - ---------------------------------- (Signature)* ROBERT L. GIPSON INDEX TO EXHIBITS PAGE ----------------- ---- EXHIBIT 1 Agreement to Make a Joint Filing 10 * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EXHIBIT 1 TO SCHEDULE 13G ------------------------- MARCH 3, 2003 ------------------------- The undersigned hereby agree that this Schedule 13g is filed on behalf of each of the parties. Date: 3/3/03 INGALLS & SNYDER LLC BY: /s/ EDWARD H. OBERST - ---------------------------------- (Signature)* EDWARD H. OBERST MANAGING DIRECTOR - ---------------------------------- Date: 3/3/03 INGALLS & SNYDER VALUE PARTNERS, L.P. BY: /s/ THOMAS O. BOUCHER JR. - ---------------------------------- (Signature)* THOMAS O BOUCHER JR. GENERAL PARTNER Date: 3/3/03 /s/ THOMAS O. BOUCHER JR. - ---------------------------------- (Signature)* THOMAS O. BOUCHER JR. Date: 3/3/03 /s/ ROBERT L. GIPSON - ---------------------------------- (Signature)* ROBERT L. GIPSON -----END PRIVACY-ENHANCED MESSAGE-----